1318792-65-2

Upstream product

• 1318792-63-0 AZD₇₉₂₉ 
• 104-15-4 toluene-4-sulfonic acid 
• 25574-11-2 3-(4-bromophenyl)propanol 
• 153993-80-7 [3-(4-bromophenyl)propoxy](tert-butyl)dimethylsilane 
• 1643-30-7 3-(4-bromophenyl)propionic acid 
• 6966-01-4 methyl 3-amino-6-bromopyrazine-2-carboxylate 
• 486422-03-1 3-amino-6-bromo-N-pyridin-3-ylpyrazine-2-carboxamide 
• 486424-37-7 3-amino-6-bromo-pyrazine-2-carboxylic acid 
• 936023-12-0 2-{4-[3-(tert-butyl-dimethyl-silanyloxy)-propyl]-phenyl}-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane 
• 1318792-84-5 tert-butyl N-[3-{4-[5-amino-6-(3-pyridylcarbamoyl)pyrazin-2-yl]phenyl}propyl]-N-(3-methoxypropyl)carbamate 
• 1318792-82-3 tert-butyl-(3-methoxypropyl)-N-{3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]propyl}carbamate 
• 1318792-81-2 tert-butyl N-[3-(4-bromophenyl)propyl]-N-(3-methoxypropyl)carbamate 
• 1318792-80-1 3-(4-bromophenyl)-N-(3-methoxypropyl)propan-1-amine 
• 1318792-79-8 3-(4-(5-amino-6-(pyridin-3-ylcarbamoyl)pyrazin-2-yl)phenyl)propyl methanesulfonate 

Relevant academic research and scientific papers

PYRAZINE DERIVATIVES

The invention concerns pyrazine derivatives of the Formula (I) or pharmaceutically-acceptable salts thereof; wherein each of n, m and R has any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use in the treatment of bone-related disorders or conditions